Implementing a Successful Corrective and Preventative Action Program

Slides:



Advertisements
Similar presentations
Project Quality Plans Gillian Sandilands Director of Quality
Advertisements

EMS Checklist (ISO model)
Checking & Corrective Action
Patients’ Perspective on HTA and Off-label use David Head MBA Chief Executive RP Fighting Blindness 25th Annual EuroMeeting 4-6 March 2013 RAI, Amsterdam.
SOP Melody Lin, Ph.D. Deputy Director, Office for Human Research Protections Director, International Activities Santiago, Chile August.
This teaching material has been made freely available by the KEMRI-Wellcome Trust (Kilifi, Kenya). You can freely download, adapt, and distribute this.
Supplier Overview of Johnson & Johnson MD&D Supplier Quality Standard Operating Procedures (SOPs) Supplier Responsibilities for Failure Investigations.
Five Star Quality Consultants Implementing ISO 9001 Corrective and Preventive Action.
OH&S Management System
Fundamentals of ISO.
Chapter 16 Software Quality Assurance
Incident Reporting Procedure
9 Closing the Project Teaching Strategies
Basics of OHSAS Occupational Health & Safety Management System
1 Accreditation and Certification: Definition  Certification: Procedures by which a third party gives written assurance that a product, process or service.
Building Quality Assurance into Clinical Trials. Objectives for Today: Define Quality in Research Describe How to Initiate Corrective and Preventative.
1. Objectives  Describe the responsibilities and procedures for reporting and investigating ◦ incidents / near-miss incidents ◦ spills, releases, ◦ injuries,
1 Thank you for visiting our site and welcome to the “Introduction to ISO 22000” Presentation that you requested. For more information.
Disclaimer The views and opinions expressed in the following PowerPoint slides are those of the individual presenter and should not be attributed to Drug.
How to audit the role of the vendor in the conduct of outsourced studies Kristel Van de Voorde Director Global Quality Regulatory Compliance Bristol-Myers.
ISO NON-CONFORMANCE, CORRECTIVE AND PREVENTIVE ACTION.
College Reviews An Overview Presented by Howard Lutwak, CIA Director of Internal Audit January 2004.
Click to add Presentation Title Arial 32, 5 line max title space line 3, title space line 4, title space line 5 Presenter Title Organization Insert your.
Software Quality Assurance SOFTWARE DEFECT. Defect Repair Defect Repair is a process of repairing the defective part or replacing it, as needed. For example,
Internal Auditing ISO 9001:2015
1 Lecture 12: Chapter 16 Software Quality Assurance Slide Set to accompany Software Engineering: A Practitioner’s Approach, 7/e by Roger S. Pressman Slides.
Swedish Risk Management System Internal management and control Aiming to Transport Administration with reasonable certainty to.
WORKSHOP ON ACCREDITATION OF BODIES CERTIFYING MEDICAL DEVICES INT MARKET TOPIC 9 CH 8 ISO MEASUREMENT, ANALYSIS AND IMPROVEMENT INTERNAL AUDITS.
RISK MANAGEMENT FOR COMMUNITY EVENTS. Today’s Session Risk Management – why is it important? Risk Management and Risk Assessment concepts Steps in the.
WORKSHOP ON ACCREDITATION OF BODIES CERTIFYING MEDICAL DEVICES INT MARKET TOPIC 6 CH 5 ISO MANAGEMENT RESPONSIBILITY Philippe Bauwin Medical.
Strategic Analyses and Interpretation: Regulatory Intelligence for Decision Making Amy N. Grant Director, Regulatory Strategy & Science ViroPharma Incorporated.
Good Laboratory Practices and Inspection Readiness Paul Swidersky President/Sr. Consultant Quality Associates, Inc.
Process-based Metadata From a DIA Presentation: eTMF – Migrating from Paper Trial Master Files to Electronic Eldin Rammell, Managing Director, Rammell.
Experiences from building a lessons- learned database for regulatory interactions Åsa Rembratt Sr Reg Intelligence Manager Novo Nordisk A/S 26th Annual.
KEVIN BEDAL LISA CARLIN MATT CARROLL ERIN NICHOLS Product Safety & Failure Analysis.
Group Sequential Tests for Delayed Responses Christopher Jennison Department of Mathematical Sciences University of Bath Lisa Hampson Department of Mathematics.
Making Comments Count for High-Impact Regulations and Guidelines in Canada, EU, Japan, and US Chairperson: Amy N. Grant Director, Regulatory Strategy &
Issues that Matter Notification and Escalation

Pipeline Safety Management Systems
OH&S Management System
- A “Portable” Implementation
Mutagenic Impurities: Guidances Update w/ CMC Perspectives
Incident Reporting And Investigation Program
Track 11 Symposium 27 June :30 – 3:00 PM
Training Course on Integrated Management System for Regulatory Body
Perspective on GCP Warning Letters
Developing an Effective Ethics Program
Molly Butler Auditor II Quality Associates, Inc.
Chapter 4 Internal Controls McGraw-Hill/Irwin
Interactive Session: Presentation of Scenarios and Q&A
COSO and ERM Committee of Sponsoring Organizations (COSO) is an organization dedicated to providing thought leadership and guidance on internal control,
NEEDS & EXPECTATIONS: INTERESTED PARTIES TO ISO & AS9100
Community-Based and Cluster-Randomized Studies –‘Pragmatic’ Approaches for Life Cycle Evidence? Florian Eichmann, PhD Principal Scientific Affairs and.
Fundamentals of ISO.
Chapter 21 Software Quality Assurance
Presenter Name Title Organization.
OH&S Management System
KMCO CAPA System Training
1 Topic Title First slide 2 line 3 line 4 line
1 Topic Title First slide 2 line 3 line 4 line
Director, Quality and Accreditation
Incident Reporting And Investigation Program
Presenter Name Title Organization.
Disclaimer The views and opinions expressed in the following PowerPoint slides are those of the individual presenter and should not be attributed to Drug.
1 Session Title 2 line 3 line 4 line
1 Session Title 2 line 3 line 4 line
1 Topic Title First slide 2 line 3 line 4 line
1 Topic Title First slide 2 line 3 line 4 line
Quality Assurance in Clinical Trials
Presentation transcript:

Implementing a Successful Corrective and Preventative Action Program Sherri A. Hubby Director, U.S. Quality Assurance Premier Research Group

Disclaimer The views and opinions expressed in the following PowerPoint slides are those of the individual presenter and should not be attributed to Drug Information Association, Inc. (“DIA”), its directors, officers, employees, volunteers, members, chapters, councils, Special Interest Area Communities or affiliates, or any organization with which the presenter is employed or affiliated. These PowerPoint slides are the intellectual property of the individual presenter and are protected under the copyright laws of the United States of America and other countries. Used by permission. All rights reserved. Drug Information Association, DIA and DIA logo are registered trademarks or trademarks of Drug Information Association Inc. All other trademarks are the property of their respective owners. Drug Information Association www.diahome.org 2 2

Presentation Objectives Setting up an Effective Corrective and Preventative Action (CAPA) Program Important Definitions/Concepts Applying the CAPA model Examples on conducting an investigation and teaching others to perform root cause analysis Recommendations on responding to audit and inspectional findings www.diahome.org

Important Definitions: Corrective Actions: The process of reacting to an existing product problem, customer complaint or other nonconformity/non-compliance and fixing it. Preventative Actions: A process for detecting potential problems or nonconformance’s and eliminating them.

Reasons for implementing CAPA Both FDA and ISO have requirements for a good quality system A poor quality system can result in financial, regulatory and loss of business impact Having the ability to correct existing problems or implementing systems to prevent potential problems boost confidence and increases customer satisfaction

What are the basics of writing a CAPA? Requires following an established problem-solving process Must understand how to conduct Root Cause Analysis Requires thorough documentation of each step Usually requires training on how to conduct an investigation.

How do I get started? Define the issue Evaluate the impact of the noncompliance Conduct an Investigation Perform root cause analysis Create, Implement and Execute an Action Plan based on your investigation Conduct Follow-up assessment to verify effectiveness

What is Root Cause/ Analysis Root cause defined as a fundamental breakdown or failure of a process which, when resolved, prevents a recurrence of the problem or non-conformance Root cause analysis is defined as a method used to address a problem or non-conformance Drug Information Association www.diahome.org

Step 1 – Define the Issue Clearly define the issue or potential issue to include: Discover the source of the information Obtain a detailed explanation of the issue Collect supportive documentation to support that the noncompliance exist.

Step 2 - Evaluate the impact Evaluate the noncompliance action In terms of the immediate need for action Level of action Assess the potential impact of the issue to include: Regulatory /Liability concern Financial concern Immediate or long-term CAPA Drug Information Association www.diahome.org

Step 3: Conducting the Investigation Memo To File [Template] DATE: TO: FROM: RE: (List ISSUES) Issue Identified: Background: Investigation Conducted: Root Cause Analysis: Corrective and Preventative Action Plan (CAPA): Drug Information Association www.diahome.org

The Investigation should include… Who reported the issue How you became aware of the issue Who conducted the investigation What did the investigation consist of Where did the investigation take place When was the investigation conducted How was the investigation conducted. State the process used at the time the issue was discovered Your investigation should describe what your investigation consisted of.. Be sure and review the original source documents when conducting an investigation and include a list of the documents reviewed. In your write-up, be sure to be objective Drug Information Association www.diahome.org

Step 4 – Conduct Root Cause Analysis The Root-Cause Analysis (based on your investigation) should document all possible reasons that led to the issue. For example: Employee not following current procedure (be specific what part of the procedure was not followed); The current process not addressing this specific situation (interpretation of procedures); Employee not trained on current process Drug Information Association www.diahome.org

Understanding Root Cause Analysis Analyzing the Symptom Analyzing the Root Cause Assumes Employees are the cause Is process driven Employees are one part of the process Assumes issue is due to poor employee training Conducts investigation to find out why the noncompliance occurred. Implements corrective and preventative action to reduce chance of error recurring Assumes no time or resources to address cause of the noncompliance Management sees this as a critical issue that requires an effective solution to prevent it from happening again. Drug Information Association www.diahome.org

Step 5: Document CAPA Document what corrective actions were taken to prevent this issue from happening again including details on how it was implemented. For example: A new procedure was required to be written and implemented as a result of the corrective action Retraining of employees due to failure to follow or understand process Extra quality checks put in place to ensure monitoring visits completed approved and provided to the sponsor on time The CAPA should give the auditor some type of assurance that this type of issue will not happen again. Drug Information Association www.diahome.org

CAPA Quality System includes: Documentation Method (forms, tracking system) ID solutions (Corrective/Preventative) Define prioritization of CAPA Conduct Impact Analysis (Define risk) Procedures must be documented Verify and Validate processes and procedures Investigate to find root cause Implement, Measure, Monitor progress Determine source of input Obtain management review/support Decide how to analyze inputs Includes Corrective Action Plan Define measure for containment Distribute/share info (Lessons learned) Drug Information Association www.diahome.org

Step 5 – Conducting Effectiveness Checks Verify and assess effectiveness of the CAPA by conducting internal assessments/audits to verify: That actions documented in the CAPA report were completed as promised That supportive documents are available as evidence, i.e., training records, SOP modifications, updated data management plans or essential document trackers For employee retraining, conduct checks to ensure that processes are being followed Drug Information Association www.diahome.org

Prevent Risk – Establish a Risk Assessment Step 1: Begin by collecting information from stakeholders, in-house specialist, external consultants Step 2: Ask questions to identify risk What is the cause of the risk? What can be done to prevent the threat from occurring? If the threat does occur, what is the plan of action? How will the plan for dealing with the threat be implemented? Step 3: Measure the risk Step 4: Make adjustments to the project plan to eliminate threats (risk) & identify opportunity to add value Step 5: Define & follow action plan & post-review www.diahome.org

Q9 Risk Mgt. Concepts Most Interactive Least interactive Initial Quality Risk Mgt. Assessment Identify Risk – Assess Impact on Patient Safety, Product Quality, and Data Integrity Most Interactive Perform Risk Assessments and Hazard Analysis/ Evaluation Risk Reduction/Strategy and Operations Controls Least interactive Risk Acceptance/Test and Implement Controls Review Events/Monitoring System

Implement Q9 Risk Mgt. Process Initial Quality Risk Mgt. Assessment Identify Risk – Assess Impact on Patient Safety, Product Quality, and Data Integrity High Impact Perform Specific Risk Assessments A nd Evaluation Perform Detained Risk Reduction (Hazard Analysis) Low Impact Select Risk Acceptance/Controls Review Events (Post-Production Controls)

QA RISK INDEX RISK CONTROL INDEX LOW RISK MEDIUM RISK HIGH RISK FREQUENCY OF USE 3 = Used often 2 – Medium use 1 = Seldom use A one-off process or vendor used on a small Study Used on >1 or 2 studies Preferred Provider or part of a SOP within CRO REGULATORY RISK 3 = High risk 2 = Medium risk 1 = Low risk Minor findings Major findings Critical Findings patient safety, data integrity BUSINESS RISK Small one-off studies with smaller sponsors Studies with mid to large pharma High Income Study with Large Sponsor Low 3 - 5 Medium 5-7 High 7-9

QA RISK EXAMPLE RISK CONTROL INDEX VENDOR A VENDOR B VENDOR C FREQUENCY OF USE Used rarely for archiving FDA regulated records = 1 Used on >1 or 2 studies for monitoring = 2 Preferred Provider - Assigned highest score of = 3 REGULATORY RISK Original training record lost, but scanned copy available; Minor finding = 1 Major findings – some monitoring visit reports were missing = 7 Critical Findings on unreported SAEs, data integrity issues = 9 BUSINESS RISK Small one-off studies with smaller sponsors, but not all processes documented = 2 Critical Risk – Risk for company not using qualified/trained monitors High Income Study with Large Sponsors and FDA reportable

In Summary… Having an effective CAPA systems allows organizations to develop systematic risk systems to reduce probability of known risk and to identify emerging risk at the lowest levels Implementation of risk assessment allows organizations to understand and be prepared for: Questions on what might go wrong Probability of reoccurrence Consequences of severity Proactively identifying and preventing recurring issues Anyone can be taught how to perform root cause analysis Don’t forget to conduct quality checks to ensure CAPAs are implemented and effective

Questions???? Drug Information Association www.diahome.org